EdgarLookup

TrueBlue, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that TrueBlue, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-7.5%
Return on Assets
Net income ÷ assets
1.33x
Debt-to-Equity
Total liabilities ÷ equity

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $367.84M Feb 18, 2026
FY2025 Dec 29, 2024 $406.39M Feb 18, 2026
FY2025 Dec 31, 2023 $506.06M Feb 18, 2026
FY2024 Dec 25, 2022 $602.14M Feb 19, 2025
FY2023 Dec 26, 2021 $560.32M Feb 21, 2024
FY2022 Dec 27, 2020 $440.65M Feb 15, 2023
FY2019 Dec 29, 2019 $150.34M Feb 24, 2020
FY2019 Sep 29, 2019 $169.12M Feb 24, 2020
FY2019 Jun 30, 2019 $158.32M Feb 24, 2020
FY2019 Mar 31, 2019 $148.38M Feb 24, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 ($47.96M) Feb 18, 2026
FY2025 Dec 29, 2024 ($125.75M) Feb 18, 2026
FY2025 Dec 31, 2023 ($14.17M) Feb 18, 2026
FY2024 Dec 25, 2022 $62.27M Feb 19, 2025
FY2023 Dec 26, 2021 $61.63M Feb 21, 2024
FY2022 Dec 27, 2020 ($141.84M) Feb 15, 2023
FY2019 Dec 29, 2019 $8.72M Feb 24, 2020
FY2019 Sep 29, 2019 $26.68M Feb 24, 2020
FY2019 Jun 30, 2019 $19.41M Feb 24, 2020
FY2019 Mar 31, 2019 $8.28M Feb 24, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 ($46.63M) Feb 18, 2026
FY2025 Dec 29, 2024 ($92.78M) Feb 18, 2026
FY2025 Dec 31, 2023 ($23.85M) Feb 18, 2026
FY2024 Dec 25, 2022 $72.19M Feb 19, 2025
FY2023 Dec 26, 2021 $68.44M Feb 21, 2024
FY2022 Dec 27, 2020 ($174.88M) Feb 15, 2023
FY2019 Dec 29, 2019 $7.34M Feb 24, 2020
FY2019 Sep 29, 2019 $29.19M Feb 24, 2020
FY2019 Jun 30, 2019 $20.89M Feb 24, 2020
FY2019 Mar 31, 2019 $8.76M Feb 24, 2020

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $371.09M Feb 18, 2026
FY2025 Dec 29, 2024 $410.87M Feb 18, 2026
FY2025 Dec 31, 2023 $494.60M Feb 18, 2026
FY2024 Dec 25, 2022 $500.69M Feb 19, 2025
FY2023 Dec 26, 2021 $464.32M Feb 21, 2024
FY2022 Dec 27, 2020 $408.31M Feb 15, 2023
FY2019 Dec 29, 2019 $133.98M Feb 24, 2020
FY2019 Sep 29, 2019 $131.19M Feb 24, 2020
FY2019 Jun 30, 2019 $127.60M Feb 24, 2020
FY2019 Mar 31, 2019 $129.66M Feb 24, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 ($58.04M) Feb 18, 2026
FY2025 Dec 29, 2024 ($17.06M) Feb 18, 2026
FY2025 Dec 31, 2023 $34.75M Feb 18, 2026
FY2024 Dec 25, 2022 $120.50M Feb 19, 2025
FY2023 Dec 26, 2021 $20.44M Feb 21, 2024
FY2022 Dec 27, 2020 $152.53M Feb 15, 2023
FY2021 Dec 29, 2019 $93.53M Feb 16, 2022
FY2020 Dec 30, 2018 $125.69M Feb 22, 2021
FY2019 Dec 31, 2017 $100.13M Feb 24, 2020
FY2018 Jan 1, 2017 $260.70M Feb 22, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $15.68M Feb 18, 2026
FY2025 Dec 29, 2024 $24.15M Feb 18, 2026
FY2025 Dec 31, 2023 $31.28M Feb 18, 2026
FY2024 Dec 25, 2022 $30.63M Feb 19, 2025
FY2023 Dec 26, 2021 $35.01M Feb 21, 2024
FY2022 Dec 27, 2020 $27.07M Feb 15, 2023
FY2021 Dec 29, 2019 $28.12M Feb 16, 2022
FY2020 Dec 30, 2018 $17.05M Feb 22, 2021
FY2019 Dec 31, 2017 $21.96M Feb 24, 2020
FY2018 Jan 1, 2017 $29.04M Feb 22, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $638.67M Feb 18, 2026
FY2025 Dec 29, 2024 $675.38M Feb 18, 2026
FY2024 Dec 31, 2023 $899.38M Feb 19, 2025
FY2023 Dec 25, 2022 $1.02B Feb 21, 2024
FY2022 Dec 26, 2021 $1.03B Feb 15, 2023
FY2021 Dec 27, 2020 $980.58M Feb 16, 2022
FY2020 Dec 29, 2019 $1.14B Feb 22, 2021
FY2019 Dec 30, 2018 $1.11B Feb 24, 2020
FY2018 Dec 31, 2017 $1.11B Feb 22, 2019
FY2017 Jan 1, 2017 $1.13B Feb 26, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $364.11M Feb 18, 2026
FY2025 Dec 29, 2024 $360.02M Feb 18, 2026
FY2024 Dec 31, 2023 $441.51M Feb 19, 2025
FY2023 Dec 25, 2022 $523.09M Feb 21, 2024
FY2022 Dec 26, 2021 $540.16M Feb 15, 2023
FY2021 Dec 27, 2020 $543.39M Feb 16, 2022
FY2020 Dec 29, 2019 $510.18M Feb 22, 2021
FY2019 Dec 30, 2018 $523.41M Feb 24, 2020
FY2018 Dec 31, 2017 $554.18M Feb 22, 2019
FY2017 Jan 1, 2017 $605.27M Feb 26, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $274.56M Feb 18, 2026
FY2025 Dec 29, 2024 $315.36M Feb 18, 2026
FY2025 Dec 31, 2023 $457.87M Feb 18, 2026
FY2025 Dec 25, 2022 $496.32M Feb 18, 2026
FY2024 Dec 26, 2021 $493.07M Feb 19, 2025
FY2023 Dec 27, 2020 $437.19M Feb 21, 2024
FY2022 Dec 29, 2019 $625.97M Feb 15, 2023
FY2021 Dec 30, 2018 $591.44M Feb 16, 2022
FY2020 Dec 31, 2017 $554.85M Feb 22, 2021
FY2019 Jan 1, 2017 $525.18M Feb 24, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $42.50M Feb 18, 2026
FY2025 Dec 29, 2024 $24.54M Feb 18, 2026
FY2025 Dec 31, 2023 $84.11M Feb 18, 2026
FY2024 Dec 25, 2022 $93.78M Feb 19, 2025
FY2023 Dec 26, 2021 $94.54M Feb 21, 2024
FY2022 Dec 27, 2020 $94.87M Feb 15, 2023
FY2021 Dec 29, 2019 $237.50M Feb 16, 2022
FY2020 Dec 30, 2018 $237.29M Feb 22, 2021
FY2019 Dec 31, 2017 $226.69M Feb 24, 2020
FY2018 Jan 1, 2017 $224.22M Feb 22, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $296.20M Feb 18, 2026
FY2025 Dec 29, 2024 $337.55M Feb 18, 2026
FY2024 Dec 31, 2023 $478.58M Feb 19, 2025
FY2023 Dec 25, 2022 $516.33M Feb 21, 2024
FY2022 Dec 26, 2021 $508.81M Feb 15, 2023
FY2021 Dec 27, 2020 $452.02M Feb 16, 2022
FY2020 Dec 29, 2019 $639.21M Feb 22, 2021
FY2019 Dec 30, 2018 $606.09M Feb 24, 2020
FY2018 Dec 31, 2017 $561.65M Feb 22, 2019
FY2017 Jan 1, 2017 $536.61M Feb 26, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 $24.51M Feb 18, 2026
FY2025 Dec 29, 2024 $22.54M Feb 18, 2026
FY2024 Dec 31, 2023 $61.89M Feb 19, 2025
FY2023 Dec 25, 2022 $72.05M Feb 21, 2024
FY2022 Dec 26, 2021 $49.90M Feb 15, 2023
FY2021 Dec 27, 2020 $62.51M Feb 16, 2022
FY2020 Dec 29, 2019 $37.61M Feb 22, 2021
FY2019 Dec 30, 2018 $46.99M Feb 24, 2020
FY2018 Dec 31, 2017 $28.78M Feb 22, 2019
FY2017 Jan 1, 2017 $34.97M Feb 26, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2019 Dec 29, 2019 $37.10M Feb 24, 2020
FY2019 Dec 30, 2018 $80.00M Feb 24, 2020
FY2018 Dec 31, 2017 $118.76M Feb 22, 2019
FY2017 Jan 1, 2017 $137.63M Feb 26, 2018
FY2016 Dec 25, 2015 $245.66M Feb 24, 2017
FY2014 Dec 26, 2014 $201.65M Feb 23, 2015
FY2014 Dec 27, 2013 $31.92M Feb 23, 2015

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 (1) Feb 18, 2026
FY2025 Dec 29, 2024 (4) Feb 18, 2026
FY2025 Dec 31, 2023 0 Feb 18, 2026
FY2024 Dec 25, 2022 1 Feb 19, 2025
FY2023 Dec 26, 2021 1 Feb 21, 2024
FY2022 Dec 27, 2020 (4) Feb 15, 2023
FY2019 Dec 29, 2019 0 Feb 24, 2020
FY2019 Sep 29, 2019 0 Feb 24, 2020
FY2019 Jun 30, 2019 0 Feb 24, 2020
FY2019 Mar 31, 2019 0 Feb 24, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 (1) Feb 18, 2026
FY2025 Dec 29, 2024 (4) Feb 18, 2026
FY2025 Dec 31, 2023 0 Feb 18, 2026
FY2024 Dec 25, 2022 1 Feb 19, 2025
FY2023 Dec 26, 2021 1 Feb 21, 2024
FY2022 Dec 27, 2020 (4) Feb 15, 2023
FY2019 Dec 29, 2019 0 Feb 24, 2020
FY2019 Sep 29, 2019 0 Feb 24, 2020
FY2019 Jun 30, 2019 0 Feb 24, 2020
FY2019 Mar 31, 2019 0 Feb 24, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 28, 2025 29.99M Feb 18, 2026
FY2025 Dec 29, 2024 29.59M Feb 18, 2026
FY2024 Dec 31, 2023 31.25M Feb 19, 2025
FY2023 Dec 25, 2022 32.73M Feb 21, 2024
FY2022 Dec 26, 2021 34.86M Feb 15, 2023
FY2021 Dec 27, 2020 35.49M Feb 16, 2022
FY2020 Dec 29, 2019 38.59M Feb 22, 2021
FY2019 Dec 30, 2018 40.05M Feb 24, 2020
FY2018 Dec 31, 2017 41.10M Feb 22, 2019
FY2017 Jan 1, 2017 42.17M Feb 26, 2018